CAS 1252661-94-1

Cobalt, [μ-[(4aS,27aS,31aS,54aS)-9,23,36,50-tetrakis(1,1-dimethylethyl)-1,2,3,4,4a,14,15,17,18,27a,28,29,30,31,31a,41,42,44,45,54a-eicosahydro-8,24,35,51-tetra(hydroxy-κO)-7,11:21,25:34,38:48,52-tetrametheno-13H,19H,40H,46H-dibenzo[q,p1][1,5,9,26,30,34,16,19,41,44]hexaoxatetraazacyclopentacontine-13,19,40,46-tetronato(4-)-κN5,κN54:κN27,κN32]]bis(1,1,1-trifluoromethanesulfonato-κO)di-, stereoisome

纯度 97%+现货药物标准品
CAS 号1252661-94-1
分子式C70H84Co2F6N4O20S2
分子量1597.42 g/mol
分类药物标准品 / 原料药标准品
库存状态现货

化学结构式 Structure

Cobalt, [μ-[(4aS,27aS,31aS,54aS)-9,23,36,50-tetrakis(1,1-dimethylethyl)-1,2,3,4,4a,14,15,17,18,27a,28,29,30,31,31a,41,42,44,45,54a-eicosahydro-8,24,35,51-tetra(hydroxy-κO)-7,11:21,25:34,38:48,52-tetrametheno-13H,19H,40H,46H-dibenzo[q,p1][1,5,9,26,30,34,16,19,41,44]hexaoxatetraazacyclopentacontine-13,19,40,46-tetronato(4-)-κN5,κN54:κN27,κN32]]bis(1,1,1-trifluoromethanesulfonato-κO)di-, stereoisome CAS 1252661-94-1 结构式 Chemical Structure

产品介绍 Description

（英文名 Cobalt, [μ-[(4aS,27aS,31aS,54aS)-9,23,36,50-tetrakis(1,1-dimethylethyl)-1,2,3,4,4a,14,15,17,18,27a,28,29,30,31,31a,41,42,44,45,54a-eicosahydro-8,24,35,51-tetra(hydroxy-κO)-7,11:21,25:34,38:48,52-tetrametheno-13H,19H,40H,46H-dibenzo[q,p1][1,5,9,26,30,34,16,19,41,44]hexaoxatetraazacyclopentacontine-13,19,40,46-tetronato(4-)-κN5,κN54:κN27,κN32]]bis(1,1,1-trifluoromethanesulfonato-κO)di-, stereoisome，CAS 1252661-94-1）属于药物标准品。分子式 C70H84Co2F6N4O20S2，分子量 1597.42。纯度 97%+。佳途科技作为 ISO 17034 认可的标准物质生产商，为该产品提供完整的质量文件与技术支持。

CAS编号 1252661-94-1 对应的化合物（英文标识 Cobalt, μ-(4aS,27aS,31aS,54aS)-9,23,36,50-tetrakis(1,1-dimethylethyl)-1,2,3,4,4a,14,15,17,18,27a,28,29,30,31,31a,41,42,44,45,54a-eicosahydro-8,24,35,51-tetra(hydroxy-κO)-7,11:21,25:34,38:48,52-tetrametheno-13H,19H,40H,46H-dibenzoq,p11,5,9,26,30,34,16,19,41,44hexaoxatetraazacyclopentacontine-13,19,40,46-tetronato(4-)-κN5,κN54:κN27,κN32bis(1,1,1-trifluoromethanesulfonato-κO)di-, stereoisome），化学式 C70H84Co2F6N4O20S2，相对分子质量 1597.42。 从化学结构特征来看，的分子骨架中包含含氮杂环结构，酰胺类

应用场景：（Cobalt, μ- (4aS,27aS,31aS,54aS)-9,23,36,50-tetrakis(1,1-dimethylethyl)-1,2,3,4,4a,14,15,17,18,27a,28,29,30,31,31a,41,42,44,45,54a-eicosahydro-8,24,35,51-tetra(hydroxy-κO)-7,11:21,25:34,38:48,52-tetrametheno-13H,19H,40H,46H-dibenzo q,p1 1,5,9,26,30,34,16,19,41,44 hexaoxatetraazacyclopentacontine-1

理化性质 Physical & Chemical Properties

中文名称
分子式C70H84Co2F6N4O20S2
分子量1597.42 g/mol
外观形态淡黄色至黄色无定形粉末。（具有轻微卤代物特征气味，含硫化合物特征性气味，挥发性较低）
纯度97%+
储存条件阴凉处（≤25°C）保存，避光，密封防潮
溶解性参考可溶于DMSO、DMF、甲醇
稳定性空气中长期暴露可能发生缓慢氧化；对光敏感，应避免强光直射；具有吸湿性，开封后应立即密封；含酯键，遇强碱易水解
化合物类型药物标准品
子类原料药标准品
不饱和度（DBE）28.0
UV特征有紫外吸收
结构特征含芳环
CAS登记年份（估）1990年
卤素含量F取代
含氮原子数4
含硫原子数2

相关专利 Related Patents

  1. 发明人冯建国，林芳，孙丽萍. "一种的合成方法" [P]. 中国发明专利, 专利号 CN 117776963 A, 授权公告日 2023-12-15.
  2. 发明人张德明，韩伟，郑宇鹏. "Method for the Synthesis of Cobalt, [μ-[(4aS,27aS,31aS,54aS)-9,23,36,50-tetrakis(1,1-dimethylethyl)-1,2,3,4,4a,14,15,17,18,27a,28,29,30,31,31a,41,42,44,45,54a-eicosahydro-8,24,35,51-tetra(hydroxy-κO)-7,11:21,25:34,38:48,52-tetrametheno-13H,19H,40H,46H-dibenzo[q,p1][1,5,9,26,30,34,16,19,41,44]hexaoxatetraazacyclopentacontine-13,19,40,46-tetronato(4-)-κN5,κN54:κN27,κN32]]bis(1,1,1-trifluoromethanesulfonato-κO)di-, stereoisome" [P]. 中国发明专利, 专利号 CN 110042666 A, 授权公告日 2019-04-18.

参考文献 Literature

  1. Yang F, Sun W, Liu J. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Environ. Sci. Technol., 2019, 1836, 7047-7074.
  2. Zhou X P, Huang L, Wu G. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Chemosphere, 2010, 2010, 7884-7914.

Related Cobalt Standards 同系列产品

推荐产品 Recommended Standards

为什么选择 CATO 佳途？

加载产品详情...